Postoperative Endophthalmitis Management (125)

Warning

exp date isn't null, but text field is

A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments.

Clinical judgement should be exercised on the applicability of any guideline, influenced by individual patient characteristics. Clinicians should be mindful of the potential for harmful polypharmacy and increased susceptibility to adverse drug reactions in patients with multiple morbidities or frailty.

If, after discussion with the patient or carer, there are good reasons for not following a guideline, it is good practice to record these and communicate them to others involved in the care of the patient.

Click here to access this guideline

Last reviewed: 10 May 2022

Next review: 31 May 2025

Author(s): Jennifer Hind

Version: 5

Approved By: Area Drugs and Therapeutics Committee Important

Document Id: 125